BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

PeriGen Webinar Presents Challenges With Category II Fetal Heart Rate Patterns


12/9/2013 10:06:49 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PRINCETON, NJ--(Marketwired - December 09, 2013) -

PeriGen, Inc.

WHAT:
Obstetrics (OB) physician expert Thomas Garite, M.D., editor-in-chief of the American Journal of Obstetrics and Gynecology (AJOG), director of research and education for Obstetrics at Pediatrix Medical Group, and chief clinical officer of PeriGen, will present a free webinar titled "Problems with Category II Fetal Heart Rate Patterns."

The webcast is part of PeriGen's inaugural "Excellence in Perinatal Care Webinar Series" created to explore methods to optimize labor and delivery (L&D) care excellence for mothers and infants.

WHY:
The National Institute of Child Health and Human Development (NICHD) defined terminology and assessment of electronic fetal monitoring (EFM) in three categories have improved standardization in communication, but may have created a problem with management of the majority of patterns. The question is: Can we do better?

Dr. Garite discusses the shortcomings of Category II EFM and the latest viewpoints on a new management algorithm. Obstetric physicians and nurses, educators, nurse managers, chief nursing officers, patient safety advocates, risk managers and other L&D care stakeholders are invited to register.

Attendees will learn:

  • Limitations of the NICHD Fetal Heart Rate Pattern Classification system
  • Identified areas where Category II patterns are not helpful in patient management
  • An alternative management scheme for Category II fetal heart rate patterns

INTERVIEW OPPTY
Thomas Garite, M.D., chief clinical officer of PeriGen -- OB and maternal fetal medicine physician consultant, AJOG editor, research program director, and foundation chair.

Post-event interviews can be arranged.

TIME/DATE:
Noon to 1 p.m. EST, Wednesday, Dec. 11, 2013

REGISTER:
To register for the complimentary webinar, click here.

PeriGen, Inc. is an innovative provider of fetal surveillance systems employing patented, pattern-recognition and obstetrics technologies that empower perinatal clinicians to make confident, real-time decisions about the mothers and babies in their care. PeriGen's customer-centric team of clinicians and technologists builds the most advanced systems available to augment obstetric decision-making and improve communications among the clinical team at the point of care, while supporting data flow between healthcare IT systems.


Media Contact:
Angela Jenkins
Amendola Communications
720.859.6930
Email Contact

PeriGen Contact:
Suzanne Trajkoski
Marketing Director
609.228.8346
Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES